HER2/Neu Positive Active Not Recruiting Phase 3 Trials for Pertuzumab (DB06366)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02003209Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerTreatment